MAU2 and hyperlipidemia: The incidences of the NCAN C-C (G2), TM6SF2 T-A (G3), TM6SF2 C-A (G5), CILP2 G-T (G6), PBX4-SUGP1 G-C (G8), MAU2 G-G-G-C (G9), MAU2 G-A-G-C (G10), MAU2 C-G-A-T (G12), and MAU2 C-A-G-T (G13) haplotypes were significantly different between the hyperlipidemia and normal groups (P < 0.05 for all).